Skip to main content
logo
Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · Real-Time Price · USD
0.1500
-0.0030 (-1.96%)
Sep 18, 2026, 4:00 PM EDT - Market closed

Catheter Precision Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
1.921.110.820.730.60.480.420.40.440.440.440.310.180.090.010.020.020.030.020.02
Revenue Growth (YoY)
219.17%130.35%95.00%82.96%37.61%9.57%-4.98%27.07%140.88%387.78%3057.14%1552.63%686.96%233.33%-36.36%11.77%---91.51%-
Cost of Revenue
10.090.060.050.050.050.040.040.030.030.030.020.020.080.160.510.751.211.561.64
Gross Profit
0.911.010.760.680.550.430.380.360.40.410.410.290.160.01-0.15-0.49-0.73-1.18-1.54-1.62
Selling, General & Admin
12.0811.1512.0812.4212.3512.1811.3510.9810.849.5517.1222.3523.1224.1816.2512.4813.1814.115.4817.66
Research & Development
0.90.910.860.630.410.340.270.170.220.270.480.641.263.526.399.9712.1912.6212.2511.94
Operating Expenses
12.9712.0612.9413.0412.7612.5211.6211.1511.069.8217.622.9924.3827.722.6422.4525.3626.7227.7329.61
Operating Income
-12.06-11.04-12.18-12.37-12.2-12.08-11.24-10.79-10.66-9.4-17.19-22.7-24.21-27.68-22.79-22.94-26.09-27.9-29.27-31.23
Interest Expense
-0.49-0.35-0.28-0.25-0.2-0.14-0.09-0.02-0.01-0--0.02--------
Interest & Investment Income
0.020.020.030.070.060.070.080.10.20.310.350.250.190.07-0.040.010.01-0.03
Other Non Operating Income (Expenses)
11.116.885.15-1.53-3.49-3.32-2.25-0.970.987.17.25.444.710.110.1-0.020.01-0.01-0.01-0.04
EBT Excluding Unusual Items
-1.42-4.5-7.28-14.08-15.83-15.48-13.5-11.68-9.49-2-9.64-17.02-19.32-27.51-22.69-22.92-26.08-27.9-29.28-31.23
Merger & Restructuring Charges
-0.1-----------0.1-0.65-4.17-4.17-4.07-3.53---
Impairment of Goodwill
----------4.85-60.93-60.93-60.93-56.09------
Gain (Loss) on Sale of Investments
-1.93--0.120.01---------------
Asset Writedown
-7-7-7-----------------
Other Unusual Items
-3.37-3.26-3.26--------------2.022.022.02
Pretax Income
-13.81-16.6-19.51-15.93-17.78-15.6-13.5-11.68-9.49-6.85-70.57-78.06-80.9-87.77-26.86-26.99-29.6-25.88-27.26-29.21
Income Tax Expense
-0.62-1.26-1.811.551.472.423.14----000000000.01
Earnings From Continuing Operations
-13.19-15.34-17.7-17.48-19.25-18.01-16.64-11.68-9.49-6.85-70.57-78.06-80.9-87.77-26.87-26.99-29.61-25.88-27.26-29.22
Earnings From Discontinued Operations
----------------3.082.552.191.99
Net Income to Company
-13.19-15.34-17.7-17.48-19.25-18.01-16.64-11.68-9.49-6.85-70.57-78.06-80.9-87.77-26.87-26.99-26.53-23.33-25.07-27.23
Minority Interest in Earnings
0.180.520.510.440.35---------------
Net Income
-13.01-14.82-17.18-17.03-18.9-18.01-16.64-11.68-9.49-6.85-70.57-78.06-80.9-87.77-26.87-26.99-26.53-23.33-25.07-27.23
Preferred Dividends & Other Adjustments
0.621.36-5.165.165.165.16---0.80.80.80.8------
Net Income to Common
-13.63-16.18-17.18-22.19-24.06-23.17-21.8-11.68-9.49-6.85-71.37-78.86-81.7-88.57-26.87-26.99-26.53-23.33-25.07-27.23
Net Income Growth (YoY)
--------------------
Shares Outstanding (Basic)
2111000000000-------
Shares Outstanding (Diluted)
2111000000000-------
Shares Change (YoY)
318.71%376.73%529.09%1292.59%1154.91%784.31%493.94%149.88%158.09%-----------
EPS (Basic)
-6.82-10.93-15.90-28.39-50.46-74.63-126.92-208.17-249.79-195.02-2467.83-3510.91-5549.38-------
EPS (Diluted)
-6.82-10.93-15.90-28.39-50.46-74.63-126.92-208.17-249.79-195.02-2467.83-3510.91-5549.38-------
EPS Growth (YoY)
--------------------

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
-9.37-8.77-8.31-9.67-10.25-9.72-9.34-8.38-7.44-10.57-20.7-21.83-24.97-26.11-22.59-25.3-27.69-28.36-27.89-
Free Cash Flow Per Share
-4.70-5.92-7.69-12.37-21.50-31.31-54.36-149.32-195.91-301.03-715.57-971.86-1695.76-------
Gross Margin
47.73%91.52%92.31%92.60%92.33%90.02%90.00%90.48%92.20%94.31%93.21%92.67%90.61%15.56%------
Operating Margin
-629.76%-996.66%-1487.30%-1693.97%-2034.00%-2512.06%-2676.91%-2704.01%-2444.95%-2141.91%-3888.01%-7229.30%-13376.24%-30760.00%-162778.57%-120742.10%-113452.17%-103329.63%-133027.27%-183694.12%
Profit Margin
-711.49%-1460.20%-2098.05%-3039.86%-4010.00%-4817.26%-5190.71%-2928.32%-2176.84%-1559.68%-16147.51%-25115.29%-45137.02%-98411.11%-191892.86%-142068.42%-115339.13%-86403.70%-113954.55%-160158.82%
Free Cash Flow Margin
-489.45%-791.25%-1015.02%-1323.97%-1708.33%-2021.21%-2223.33%-2100.50%-1707.34%-2407.52%-4682.13%-6952.23%-13792.82%-29006.67%-161321.43%-133131.58%-120400.00%-105040.74%-126772.73%-
EBITDA
-10.17-9.05-10.07-10.25-10.13-9.97-9.13-8.69-8.58-8.25-15.11-21.12-23.07-26.01-22.37-22.33-25.29-26.9-28.1-29.84
D&A For EBITDA
1.891.992.122.122.082.122.112.12.091.152.081.581.141.680.420.610.8111.171.39
EBIT
-12.06-11.04-12.18-12.37-12.2-12.08-11.24-10.79-10.66-9.4-17.19-22.7-24.21-27.68-22.79-22.94-26.09-27.9-29.27-31.23
Revenue as Reported
1.10.29--0.360.14--------------
Advertising Expenses
--0.17---0.17---0.1---------
SEC Filings: 10-K · 10-Q